Has Vijay Rao, MD received payments from drug or device companies?

Yes. Drug and device makers reported $49,017 in general payments to Vijay Rao, MD across 294 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vijay Rao, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vijay Rao, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vijay Rao, MD

Hematology & Oncology · Watertown, SDNPI 1982725180

Payments from drug & device makers

$49,017in general payments, 2019–2025

Across 294 payments — averaging $166.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$15K
Puma Biotechnology, Inc.$8K
Novartis$5K
Gilead$5K
AstraZeneca$5K
E.r. Squibb & Sons, L.L.C.$2K
plus $8K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	12	$14,745
Puma Biotechnology, Inc.	3	$8,250
Novartis	15	$5,463
Gilead(2 entities)	24	$5,250
AstraZeneca(2 entities)	20	$5,097
E.r. Squibb & Sons, L.L.C.	5	$1,786
Boehringer Ingelheim	5	$1,643
AVEO Pharmaceuticals, Inc.	7	$1,093
Bristol Myers Squibb	18	$582
Sanofi	9	$450
Johnson & Johnson(2 entities)	23	$436
Tempus AI, Inc	4	$429
Janssen Scientific Affairs, LLC	5	$275
Pfizer	9	$226
Pharmacyclics LLC, An Abbvie Company	6	$213
Daiichi Sankyo Inc.	10	$210
Novocure GmbH	1	$200
Seagen Inc.	8	$187
AbbVie	4	$154
Deciphera Pharmaceuticals Inc.	3	$137
Lilly USA, LLC	7	$126
Sobi, Inc	4	$109
Regeneron Healthcare Solutions, Inc.	6	$109
GSK	3	$106
Cardinal Health 110 LLC	1	$100
Sanofi-aventis U.S. LLC	1	$99
Takeda Pharmaceuticals U.S.A., Inc.	5	$98
Eisai Inc.	6	$97
Astellas Pharma US Inc	5	$81
Coherus Oncology, Inc.	2	$78
Beigene USA, Inc.	4	$70
Merck	5	$69
Adaptive Biotechnologies Corporation	1	$67
Genentech USA, Inc.	4	$65
Bayer	3	$60
Mirati Therapeutics, Inc.	4	$60
Myriad Genetic Laboratories, Inc.	3	$58
Servier Pharmaceuticals LLC	3	$57
Progenics Pharmaceuticals, Inc.	3	$52
ADC Therapeutics America, Inc.	2	$51
Amgen	3	$44
Pharmaessentia USA Corporation	2	$40
Genentech, Inc.	1	$40
Immunogen, Inc.	2	$40
Pharmacosmos Therapeutics Inc.	2	$40
Karyopharm Therapeutics Inc.	1	$37
Beone Medicines USA, Inc.	2	$32
Rigel Pharmaceuticals, Inc.	2	$31
Jazz Pharmaceuticals Inc.	2	$30
Stemline Therapeutics Inc.	1	$27
Acrotech Biopharma Inc.	1	$27
Tolmar Pharmaceuticals, Inc.	1	$21
Springworks Therapeutics, Inc.	1	$20
Taiho Oncology, Inc.	1	$19
Epizyme, Inc.	1	$18
Ipsen Biopharmaceuticals, Inc	1	$18
Kyowa Kirin, Inc.	1	$17
Syndax Pharmaceuticals, Inc.	1	$15
Exelixis Inc.	1	$15
Morphosys, US Inc.	1	$14

How this compares

$49,017 in reported general payments places this provider in the 45th percentile of 28 hematology & oncology providers in South Dakota.

See all hematology & oncology providers in South Dakota →

Medicare billing

Part B allowed, 2024

$40,589

Medicare patients

163

Services billed

411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Watertown

Bipinkumar AminWatertown$1.3M
Ferdinand AddoWatertown$663
Steven PowellSioux Falls$8.5M
Benjamin SolomonSioux Falls$2.8M
Christopher SumeySioux Falls$2.6M
Heidi McKeanSioux Falls$2M
Kelly McCaulSioux Falls$1.5M
Jonathan BleekerSioux Falls$1M
Amy SanfordSioux Falls$837K
Waqas JehangirSioux Falls$698K

See the full list for South Dakota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →